Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ursodesoxycholic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a novel synthetic route for ursodesoxycholic acid from chenodeoxycholic acid featuring high optical purity and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN106868534B enables mild electro-catalytic synthesis. Delivers high-purity bile acids with substantial cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN105368828A enables high-yield UDCA synthesis via recombinant E. coli ensuring supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Novel chiral catalyst hydrogenation method for ursodesoxycholic acid ensures high yield and purity, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel synthesis of 3 beta-ursodesoxycholic acid via selective esterification and stereoselective reduction. High yield, mild conditions, cost-effective manufacturing solution.